Warren Eric
Esperion Therapeutics, Inc. · Chief Commercial Officer
Warren Eric is listed in filings as Chief Commercial Officer at Esperion Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 21, 2025, including sale activity. Recent filings connect the profile to Esperion Therapeutics, Inc. (ESPR). The current snapshot covers public activity from Jun 20, 2024 to Apr 21, 2025. Reported amounts are shown as $106 to $286.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $3.6k2.4k shares | SellMar 18, 2025 | $1.49 | $3.13 | |
| $446239 shares | SellFeb 19, 2025 | $1.87 | $3.13 | |
| $278123 shares | SellJan 17, 2025 | $2.26 | $3.13 | |
| $5.4k2.2k shares | SellDec 17, 2024 | $2.43 | $3.13 | |
| $427197 shares | SellNov 19, 2024 | $2.17 | $3.13 | |
| $227107 shares | SellOct 17, 2024 | $2.12 | $3.13 | |
| $4.7k2.6k shares | SellSep 17, 2024 | $1.78 | $3.13 | |
| $411211 shares | SellAug 19, 2024 | $1.95 | $3.13 | |
| $279108 shares | SellJul 17, 2024 | $2.59 | $3.13 | |
| $7.3k2.5k shares | SellJun 18, 2024 | $2.86 | $3.13 |